Corporate Actions Earnings Reports Mergers and Acquisitions Acquisitions Executive Changes Corporate Earnings SharpLink Gaming Stock Performance Management Changes Pharmaceuticals Technology Stocks Retail Stocks Profit Reports Hims & Hers Robinhood Close Brothers H&T Group Retail Sector Leadership Changes Apple Earnings Report Developer Disruptive Games NIKE, Inc. PwC Nvidia Bajaj Finance Corporate Performance Luxxfolio Holdings Inc. IPO Offerings Gemini Cybersecurity Teck Resources Mergers & Acquisitions Executive Appointments Ualá IPO Sector Performance Partnerships Earnings Surprises Galaxy Digital Updates BHP Jiuzi Holdings Strategic Partnerships Strategic Investments Kindly MD, Inc. Infosys Stock Price Movements Corporate Financing Radian Group Fair Issac Corporation Corporate Strategy TON Strategy Financial Results Corporate Governance Robinhood Markets Nike Exchange Filings Financial Performance Retail Executive Retirement Airlines Boeing Individual Stocks Electric Vehicles De La Rue Bellway Palantir Technologies Technology Companies
The deal targets Penumbra’s thrombectomy-focused neurovascular devices to deepen Boston Scientific’s cardiovascular reach.
